CD157, the Janus of CD38 but with a unique personality

Cell Biochemistry and Function

Volumn 20, Issue 4, 2002, Pages 309-322

  Ortolan, Erika ^a,b   Vacca, Paola ^a,b   Capobianco, Andrea ^a,b   Armando, Enrico ^a,b   Crivellin, Federico ^a,b   Horenstein, Alberto ^a,b   Malavasi, Fabio ^a,b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

ADP ribosyl cyclase; CD157; CD38; Ectoenzyme; NAD+ glycohydrolase

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; AMINO ACID; CD157 ANTIGEN; CD38 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL; NICOTINAMIDE ADENINE DINUCLEOTIDE; CD38 PROTEIN, HUMAN; CD38 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; CELL ADHESION; CELL CYCLE; ENZYME ACTIVITY; ENZYME STRUCTURE; GENOME ANALYSIS; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY;

JANUS;

ADP-RIBOSYL CYCLASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD38; ARTHRITIS, RHEUMATOID; CELL ADHESION; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 0036889207     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.978     Document Type: Review

References (94)

1. Goding JW, Howard MC. Ecto-enzymes of lymphoid cells. Immunol Rev 1998; 161: 5-10.
2. Kaisho T, Ishikawa J, Oritani K, et al. BST-1, a surface molecule of bone marrow stromal cell lines that facilitates pre-B-cell growth. Proc Natl Acad Sci USA 1994; 91: 5325-5329.
3. Lee BO, Ishihara K, Denno K, et al. Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum 1996; 39: 629-637.
4. Itoh M, Ishihara K, Tomizawa H, et al. Molecular cloning of murine BST-1 having homology with CD38 and aplysia ADP-ribosyl cyclase. Biochem Biophys Res Commun 1994; 203: 1309-1317.
5. Muraoka O, Tanaka H, Itoh M, Ishihara K, Hirano T. Genomic structure of human BST-1. Immunol Lett 1996; 54: 1-4.
6. Dong C, Wang J, Neame P, Cooper MD. The murine BP-3 gene encodes a relative of the CD38/NAD glycohydrolase family. Int Immunol 1994; 6: 1353-1360.
7. Dong C, Willerford D, Alt FW, Cooper MD. Genomic organization and chromosomal localization of the mouse Bp3 gene, a member of the CD38/ADP-ribosyl cyclase family. Immunogenetics 1996; 45: 35-43.
8. +-converting enzymes: Extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP-ribosyl cyclase. J Immunol 1997; 159: 3858-3865.
9. Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 1999; 49: 597-604.
10. Furuya Y, Takasawa S, Yonekura H, Tanaka T, Takahara J, Okamoto H. Cloning of a cDNA encoding rat bone marrow stromal cell antigen 1 (BST-1) from the islets of Langerhans. Gene 1995; 165: 329-330.
11. Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: A glycoprotein in search of a function. Immunol Today 1994; 15: 95-97.
12. Funaro A, Malavasi F. Human CD38, a surface receptor, an enzyme, an adhesion molecule and not a simple marker. J Biol Regul Homeost Agents 1999; 13: 54-61.
13. Englund PT. The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annu Rev Biochem 1993; 62: 121-138.
14. Okazaki IJ, Moss J. Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J Biol Chem 1998; 273: 23617-23620.
15. Bortell R, Moss J, McKenna RC, et al. Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: Role of cell surface NAD glycohydrolase and pyrophosphatase activities. J Immunol 2001; 167: 2049-2059.
16. Goldstein SC, Todd RF, III. Structural and biosynthetic features of the Mo5 human myeloid differentiation antigen. Tissue Antigens 1993; 41: 214-218.
17. McNagny KM, Cazenave PA, Cooper MD. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice. J Immunol 1988; 141: 2551-2556.
18. Hirata Y, Kimura N, Sato K, et al. ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1. FEBS Lett 1994; 356: 244-248.
19. Yamamoto-Katayama S, Sato A, Ariyoshi M, et al. Site-directed removal of N-glycosylation sites in BST-1/CD157: effects on molecular and functional heterogeneity. Biochem J 2001; 357: 385-392.
20. Chidambaram N, Chang CF. Functional role of glycosylation on the recombinant CD38/ADP-ribosyl cyclase in CHO cells. Int J Biochem Cell Biol 1998; 30: 1011-1018.
21. Prasad GS, McRee DE, Stura EA, Levitt DG, Lee HC, Stout CD. Crystal structure of aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38. Nature Struct Biol 1996; 3: 957-964.
22. Tohgo A, Takasawa S, Noguchi N, et al. Essential cysteine residues for cyclic ADP-ribose synthesis and hydrolysis by CD38. J Biol Chem 1994; 269: 28555-28557.
23. + glycohydrolase to a functional domain in the carboxyl terminus. J Immunol 1997; 158: 741-747.
24. Berthelier V, Laboureau J, Boulla G, Schuber F, Deterre P. Probing ligand-induced conformational changes of human CD38. Eur J Biochem 2000; 267: 3056-3064.
25. Kukimoto M, Nureki O, Shirouzu M, et al. Crystallization and preliminary X-ray diffraction analysis of the extracellular domain of the cell surface antigen CD38 complexed with ganglioside. J Biochem (Tokyo) 2000; 127: 181-184.
26. Sato A, Yamamoto S, Kajimura N, Oda M, Usukura J, Jingami H. Inhibitor peptide SNP-1 binds to a soluble form of BST-1/CD157 at a 2:2 stoichiometry. Eur J Biochem 1999; 264: 439-445.
27. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996; 10: 1408-1417.
28. Ferrero E, Malavasi F. The metamorphosis of a molecule: From soluble enzyme to the leukocyte receptor CD38. J Leukoc Biol 1999; 65: 151-161.
29. Katz F, Povey S, Parkar M, et al. Chromosome assignment of monoclonal antibody-defined determinants on human leukemic cells. Eur J Immunol 1983; 13: 1008-1013.
30. Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 1990; 144: 2811-2815.
31. Nakagawara K, Mori M, Takasawa S, et al. Assignment of CD38, the gene encoding human leukocyte antigen CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase), to chromosome 4p15. Cytogenet Cell Genet 1995; 69: 38-39.
32. Ishihara K, Okuyama Y, Lee BO, Itoh M, Nishikawa K, Hirano T. CD157(BST-1) workshop panel report. In Leucocyte Typing VI, Kishimoto T, Kikutai H, von dem Borne AEGK, et al. (eds). Garland Publishing: New York, 1997; 1086-1089.
33. Harada N, Santos-Argumedo L, Chang R, et al. Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38. J Immunol 1993; 151: 3111-3118.
34. Ishihara K, Kobune Y, Okuyama Y, et al. Stage-specific expression of mouse BST-1/BP-3 on the early B and T cell progenitors prior to gene rearrangement of antigen receptor. Int Immunol 1996; 8: 1395-1404.
35. Malavasi F, Caligaris-Cappio F, Milanese C, Dellabona P, Richiardi P, Carbonara AO. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells. Hum Immunol 1984; 9: 9-20.
36. Kumagai M, Coustan-Smith E, Murray DJ, et al. Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 1995; 181: 1101-1110.
37. Donis Hernandez FR, Parkhouse RM, Santos-Argumedo L. Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice. Eur J Immunol 2001; 31: 1261-1267.
38. Vicari AP, Bean AG, Zlotnik A. A role for BP-3/BST-1 antigen in early T cell development. Int Immunol 1996; 8: 183-191.
39. Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993; 150: 4244-4252.
40. Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today 1993; 14: 547-553.
41. Bean AG, Godfrey DI, Ferlin WG, et al. CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of alpha beta TCR + CD4-CD8-thymocytes. Int Immunol 1995; 7: 213-221.
42. Seki M, Fairchild S, Rosenwasser OA, Tada N, Tomonari K. An immature rat lymphocyte marker CD157: Striking differences in the expression between mice and rats. Immunobiology 2001; 203: 725-742.
43. McNagny KM, Bucy RP, Cooper MD. Reticular cells in peripheral lymphoid tissues express the phosphatidylinositol-linked BP-3 antigen. Eur J Immunol 1991; 21: 509-515.
44. Kajimoto Y, Miyagawa J, Ishihara K, et al. Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP- ribosyl cyclase activity. Biochem Biophys Res Commun 1996; 219: 941-946.
45. Todd RF, III, Roach JA, Amaout MA. The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen. Blood 1985; 65: 964-973.
46. Todd RF, III. Functional evaluation of myeloid antibodies. In Leukocyte Typing V, Schlossman SF, Boumsell L, Gilks W, et al. (eds). Oxford University Press: Oxford, 1995; 991-1093.
47. Deaglio S, Sposato P, Barisone E, et al. Analysis of human CD157 by means of murine mAbs. In Leucocyte Typing VII, Mason D (ed.). Pergamon Press: Oxford, 2002; (in press).
48. Shimoka Y, Attrep JF, Hirano T, et al. Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest 1998; 102: 606-618.
49. Ross JA, Ansell I, Hjelle JT, Anderson JD, Miller-Hjelle MA, Dobbie JW. Phenotypic mapping of human mesothelial cells. Adv Perit Dial 1998; 14: 25-30.
50. Ghannadan M, Baghestanian M, Wimazal F, et al. Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies. J Invest Dermatol 1998; 111: 689-695.
51. Wimazal F, Ghannadan M, Muller MR, et al. Expression of homing receptors and related molecules on human mast cells and basophils: A comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques. Tissue Antigens 1999; 54: 499-507.
52. Fernandez JE, Deaglio S, Donati D, et al. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents 1998; 12: 81-91.
53. Howard M, Grimaldi JC, Bazan JF, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993; 262: 1056-1059.
54. Aarhus R, Graeff RM, Dickey DM, Walseth TF, Lee HC. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium- mobilizing metabolite from NADP. J Biol Chem 1995; 270: 30327-30333.
55. + signaling. Adv Exp Med Biol 1997; 419: 411-419.
56. Takasawa S, Tohgo A, Noguchi N, et al. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 1993; 268: 26052-26054.
57. Hussain AM, Lee HC, Chang CF. Functional expression of secreted mouse BST-1 in yeast. Protein Expr Purif 1998; 12: 133-137.
58. Zocchi E, Franco L, Guida L, Calder L, De Flora A. Self- aggregation of purified and membrane-bound erythrocyte CD38 induces extensive decrease of its ADP-ribosyl cyclase activity. FEBS Lett 1995; 359: 35-40.
59. Guse AH. Cyclic ADP-ribose. J Mol Med 2000; 78: 26-35.
60. Guse AH, da Silva CP, Berg I, et al. Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 1999; 398: 70-73.
61. Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionally dependent on the TCR/CD3 complex in human T cells. FASEB J 1998; 12: 581-592.
62. + channel. Nature 1993; 364: 76-79.
63. + release in intestinal longitudinal muscle. J Biol Chem 1995; 270: 25488-25494.
64. Takasawa S, Nata K, Yonekura H, Okamoto H. Cyclic ADP- ribose in insulin secretion from pancreatic beta cells. Science 1993; 259: 370-373.
65. Funaro A, Reinis M, Trubiani O, Santi S, Di Primio R, Malavasi F. CD38 functions are regulated through an internalization step. J Immunol 1998; 160: 2238-2247.
66. +-dependent internalization of the transmembrane glycoprotein CD38 in human Namalwa B cells. FEBS Lett 1996; 396: 327-332.
67. +-dependent internalization of recombinant CD38 in CHO cells. Arch Biochem Biophys 1999; 363: 267-272.
68. Sun L, Adebanjo OA, Moonga BS, et al. CD38/ADP-ribosyl cyclase: a new role in the regulation of osteoclastic bone resorption. J Cell Biol 1999; 146: 1161-1172.
69. Khoo KM, Han MK, Park JB, et al. Localization of the cyclic ADP-ribose-dependent calcium signaling pathway in hepatocyte nucleus. J Biol Chem 2000; 275: 24807-24817.
70. Khoo KM, Chang CF. Characterization and localization of CD38 in the vertebrate eye. Brain Res 1999; 821: 17-25.
71. Yamada M, Mizuguchi M, Otsuka N, Ikeda K, Takahashi H. Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res 1997; 756: 52-60.
72. Ishihara K, Hirano T. BST-1/CD157 regulates the humoral immune responses in vivo. Chem Immunol 2000; 75: 235-255.
73. Okuyama Y, Ishihara K, Kimura N, et al. Human BST-1 expressed on myeloid cells functions as a receptor molecule. Biochem Biophys Res Commun 1996; 228: 838-845.
74. Hussain AM, Chang CF. Novel kinetics, behaviour and cell-type specificity of CD157-mediated tyrosine kinase signalling. Cell Signal 1999; 11: 891-897.
75. Liang F, Chang CF. Signalling of GPI-anchored CD157 via focal adhesion kinase in MCA102 fibroblasts. FEBS Lett 2001; 506: 207-210.
76. Martin TF. Phosphoinositide lipids as signaling molecules: Common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol 1998; 14: 231-264.
77. Funaro A, De Monte LB, Dianzani U, Fomi M, Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol 1993; 23: 2407-2411.
78. Reinis M, Morra M, Funaro A, Di Primio R, Malavasi F. Functional associations of CD38 with CD3 on the T-cell membrane. J Biol Regul Homeost Agents 1997; 11: 137-142.
79. Lund F, Solvason N, Grimaldi JC, Parkhouse RM, Howard M. Murine CD38: An immunoregulatory ectoenzyme. Immunol Today 1995; 16: 469-473.
80. Lund FE, Yu N, Kim KM, Reth M, Howard MC. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression. J Immunol 1996; 157: 1455-1467.
81. Mallone R, Funaro A, Zubiaur M, et al. Signaling through CD38 induces NK cell activation. Int Immunol 2001; 13: 397-409.
82. Deaglio S, Mallone R, Baj G, et al. Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. FASEB J 2001; 15: 580-582.
83. Deaglio S, Mallone R, Baj G, Amulfo A, Dianzani U, Malavasi F. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol 2000; 75: 99-116.
84. Sato A, Yamamoto S, Ishihara K, Hirano T, Jingami H. Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157). Biochem J 1999; 337: 491-496.
85. Hussain AM, Lee HC, Chang CF. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines. Eur J Cell Biol 2000; 79: 697-706.
86. Anani L, Coffre C, Binet C, Degenne M, Domenech J, Herault O. Expression of CD157 and CD38 antigens on human myeloid leukaemia cells: A similar pattern of modulation with differentiating inducers. Acta Haematol 2001; 105: 249-251.
87. Ozpolat B, Lopez-Berestein G, Mehta K. ATRA(ouble) in the treatment of acute promyelocytic leukemia. J Biol Regul Homeost Agents 2001; 15: 107-122.
88. 3 and mucosal TD antigenelicited IgA responses. J Immunol 1998; 161: 3974-3983.
89. Cockayne DA, Muchamuel T, Grimaldi JC, et al. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood 1998; 92: 1324-1333.
90. Shakhov AN, Nedospasov SA. Expression profiling in knockout mice: Lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture. Cytokine Growth Factor Rev 2001; 12: 107-119.
91. Staudt LM, Brown PO. Genomic views of the immune system. Annu Rev Immunol 2000; 18: 829-859.
92. Ngo VN, Korner H, Gunn MD, et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 1999; 189: 403-412.
93. Kaisho T, Oritani K, Ishikawa J, et al. Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth. J Immunol 1992; 149: 4088-4095.
94. Horejsi V, Drbal K, Cebecauer M, et al. GPI-microdomains: A role in signalling via immunoreceptors. Immunol Today 1999; 20: 356-361.